These issues may overlap with conditions treated through Hormone Replacement Therapy or Bioidentical hormone therapy, making professional guidance essential
Tirzepatide is an FDA-approved dual GIP/GLP-1 receptor agonist that reduces appetite and improves glucose control, while creatine is a widely used supplement that enhances muscle performance and mass
doi: 10.3389/fmed.2026.1698091 Received 03 September 2025 Revised 16 March 2026 Accepted 19 March 2026 Published 20 April 2026 Volume 13 - 2026 Edited by Liliana Gabriela Popa, Carol Davila University of Medicine and Pharmacy, Romania Reviewed by Manoj B
Link Cleveland Clinic
PubMed, Custodio, Hipolito M., Karin Broberg, et al
Trong s , cc sn phm n t Nht Bn lun c ngi dng nh gi cao nh c nghin cu k lng mang li cng dng v hiu qu thc s